Nexpoint Asset Management’s NextCure NXTC Stock Holding History

Nexpoint Asset Management’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,095	Closed	-$1.46M	–	230
2021 Q3	$1.46M	Sell	18,095 -1,464	-7%	-$128K	0.25%	52
2021 Q2	$1.89M	Buy	+19,559	New	+$2M	0.41%	39
2020 Q2	–	Sell	-625	Closed	-$278K	–	222
2020 Q1	$278K	Hold	625	–	–	0.05%	169
2019 Q4	$422K	Buy	+625	New	+$314K	0.03%	210

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nexpoint Asset Management's NXTC Position: Q4 2021 in Review

Nexpoint Asset Management sold out of NextCure (NXTC) in Q4 2021, closing a stake of 18,095 shares — an estimated $1.46M sold.

Nexpoint Asset Management first reported a position in NXTC in Q4 2019 and held it in 4 quarters. The position peaked at $1.89M in Q2 2021. 71 funds tracked by Wall St. Rank hold NXTC as of Q4 2021.

Nexpoint Asset Management reported no remaining NextCure position as of Q4 2021 after selling out during the quarter.
Nexpoint Asset Management sold 18,095 NextCure shares in Q4 2021, an estimated $1.46M.
Nexpoint Asset Management first reported a position in NextCure in Q4 2019 and held it in 4 quarters.
Nexpoint Asset Management's NextCure position peaked at $1.89M in Q2 2021.
71 funds tracked by Wall St. Rank held NextCure as of Q4 2021.

Based on Nexpoint Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.